These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

796 related articles for article (PubMed ID: 18252893)

  • 21. Serum concentrations of fibroblast growth factors 19 and 21 in women with gestational diabetes mellitus: association with insulin resistance, adiponectin, and polycystic ovary syndrome history.
    Wang D; Zhu W; Li J; An C; Wang Z
    PLoS One; 2013; 8(11):e81190. PubMed ID: 24260557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fasting decreases plasma FGF21 in obese subjects and the expression of FGF21 receptors in adipose tissue in both lean and obese subjects.
    Nygaard EB; Ørskov C; Almdal T; Vestergaard H; Andersen B
    J Endocrinol; 2018 Oct; 239(1):73–80. PubMed ID: 30307155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Daily physical activity, fasting glucose, uric acid, and body mass index are independent factors associated with serum fibroblast growth factor 21 levels.
    Cuevas-Ramos D; Almeda-Valdes P; Gómez-Pérez FJ; Meza-Arana CE; Cruz-Bautista I; Arellano-Campos O; Navarrete-López M; Aguilar-Salinas CA
    Eur J Endocrinol; 2010 Sep; 163(3):469-77. PubMed ID: 20566587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Klotho and fibroblast growth factors 19 and 21 serum concentrations in children and adolescents with normal body weight and obesity and their associations with metabolic parameters.
    Socha-Banasiak A; Michalak A; Pacześ K; Gaj Z; Fendler W; Socha A; Głowacka E; Kapka K; Gołąbek V; Czkwianianc E
    BMC Pediatr; 2020 Jun; 20(1):294. PubMed ID: 32546231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21.
    Iglesias P; Selgas R; Romero S; Díez JJ
    Eur J Endocrinol; 2012 Sep; 167(3):301-9. PubMed ID: 22740503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum fibroblast growth factor 21 in overweight and obese Thai children and adolescents: its relation to glucose metabolism and its change after glucose loading.
    Korwutthikulrangsri M; Mahachoklertwattana P; Chanprasertyothin S; Pongratanakul S; Poomthavorn P
    Clin Endocrinol (Oxf); 2015 Dec; 83(6):820-7. PubMed ID: 25929297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum zinc-alpha2-glycoprotein correlates with adiposity, triglycerides, and the key components of the metabolic syndrome in Chinese subjects.
    Yeung DC; Lam KS; Wang Y; Tso AW; Xu A
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2531-6. PubMed ID: 19351730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitamin D modifies the associations between circulating betatrophin and cardiometabolic risk factors among youths at risk for metabolic syndrome.
    Fu J; Hou C; Li L; Feng D; Li G; Li M; Li C; Gao S; Li M
    Cardiovasc Diabetol; 2016 Oct; 15(1):142. PubMed ID: 27716289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride.
    Li H; Fang Q; Gao F; Fan J; Zhou J; Wang X; Zhang H; Pan X; Bao Y; Xiang K; Xu A; Jia W
    J Hepatol; 2010 Nov; 53(5):934-40. PubMed ID: 20675007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The FGF21 response to fructose predicts metabolic health and persists after bariatric surgery in obese humans.
    Ter Horst KW; Gilijamse PW; Demirkiran A; van Wagensveld BA; Ackermans MT; Verheij J; Romijn JA; Nieuwdorp M; Maratos-Flier E; Herman MA; Serlie MJ
    Mol Metab; 2017 Nov; 6(11):1493-1502. PubMed ID: 29107295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum FGF21 Levels in Obese Korean Children and Adolescents.
    Baek J; Nam HK; Rhie YJ; Lee KH
    J Obes Metab Syndr; 2017 Sep; 26(3):204-209. PubMed ID: 31089518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum concentrations of fibroblast growth factor 21 are elevated in patients with congenital or acquired lipodystrophy.
    Miehle K; Ebert T; Kralisch S; Hoffmann A; Kratzsch J; Schlögl H; Stumvoll M; Fasshauer M
    Cytokine; 2016 Jul; 83():239-244. PubMed ID: 27179139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models--association with liver and adipose tissue effects.
    Xu J; Stanislaus S; Chinookoswong N; Lau YY; Hager T; Patel J; Ge H; Weiszmann J; Lu SC; Graham M; Busby J; Hecht R; Li YS; Li Y; Lindberg R; Véniant MM
    Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1105-14. PubMed ID: 19706786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma fibroblast growth factor 21 levels increase with ectopic fat accumulation and its receptor levels are decreased in the visceral fat of patients with type 2 diabetes.
    Hong ES; Lim C; Choi HY; Lee YK; Ku EJ; Moon JH; Park KS; Jang HC; Choi SH
    BMJ Open Diabetes Res Care; 2019; 7(1):e000776. PubMed ID: 31798902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circadian rhythm of circulating fibroblast growth factor 21 is related to diurnal changes in fatty acids in humans.
    Yu H; Xia F; Lam KS; Wang Y; Bao Y; Zhang J; Gu Y; Zhou P; Lu J; Jia W; Xu A
    Clin Chem; 2011 May; 57(5):691-700. PubMed ID: 21325103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum fibroblast growth factor-21 levels are associated with carotid atherosclerosis independent of established cardiovascular risk factors.
    Chow WS; Xu A; Woo YC; Tso AW; Cheung SC; Fong CH; Tse HF; Chau MT; Cheung BM; Lam KS
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2454-9. PubMed ID: 23887638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibroblast growth factor-21 and omentin-1 hepatic mRNA expression and serum levels in morbidly obese women with non-alcoholic fatty liver disease.
    Waluga M; Kukla M; Zorniak M; Kajor M; Liszka L; Dyaczynski M; Kowalski G; Zadlo D; Waluga E; Olczyk P; Buldak RJ; Berdowska A; Hartleb M
    J Physiol Pharmacol; 2017 Jun; 68(3):363-374. PubMed ID: 28820393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibroblast growth factor-21 serum concentrations are associated with metabolic and hepatic markers in humans.
    Kralisch S; Tönjes A; Krause K; Richter J; Lossner U; Kovacs P; Ebert T; Blüher M; Stumvoll M; Fasshauer M
    J Endocrinol; 2013 Feb; 216(2):135-43. PubMed ID: 23129782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postprandial changes in glucose oxidation and insulin sensitivity in metabolic syndrome: Influence of fibroblast growth factor 21 and vitamin D status.
    Pathak K; Soares MJ; Zhao Y; James AP; Sherriff JL; Newsholme P
    Nutrition; 2017 May; 37():37-42. PubMed ID: 28359360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The association of circulating irisin with metabolic risk factors in Chinese adults: a cross-sectional community-based study.
    Tang L; Tong Y; Zhang F; Chen G; Zhang YC; Jobin J; Tong N
    BMC Endocr Disord; 2019 Dec; 19(1):147. PubMed ID: 31881940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.